BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 36982322)

  • 1. Role of Klotho and AGE/RAGE-Wnt/β-Catenin Signalling Pathway on the Development of Cardiac and Renal Fibrosis in Diabetes.
    Martín-Carro B; Martín-Vírgala J; Fernández-Villabrille S; Fernández-Fernández A; Pérez-Basterrechea M; Navarro-González JF; Donate-Correa J; Mora-Fernández C; Dusso AS; Carrillo-López N; Panizo S; Naves-Díaz M; Fernández-Martín JL; Cannata-Andía JB; Alonso-Montes C
    Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SiJunZi decoction ameliorates bone quality and redox homeostasis and regulates advanced glycation end products/receptor for advanced glycation end products and WNT/β-catenin signaling pathways in diabetic mice.
    Dai X; Liu Y; Liu T; Zhang Y; Wang S; Xu T; Yin J; Shi H; Ye Z; Zhu R; Gao J; Dong G; Zhao D; Gao S; Wang X; Prentki M; Brὂmme D; Wang L; Zhang D
    J Ethnopharmacol; 2024 Jan; 319(Pt 2):117167. PubMed ID: 37716489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The changes of serum sKlotho and NGAL levels and their correlation in type 2 diabetes mellitus patients with different stages of urinary albumin.
    Wu C; Wang Q; Lv C; Qin N; Lei S; Yuan Q; Wang G
    Diabetes Res Clin Pract; 2014 Nov; 106(2):343-50. PubMed ID: 25263500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The breakdown of preexisting advanced glycation end products is associated with reduced renal fibrosis in experimental diabetes.
    Forbes JM; Thallas V; Thomas MC; Founds HW; Burns WC; Jerums G; Cooper ME
    FASEB J; 2003 Sep; 17(12):1762-4. PubMed ID: 12958202
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of atorvastatin on progression of diabetic nephropathy and local RAGE and soluble RAGE expressions in rats.
    Lu L; Peng WH; Wang W; Wang LJ; Chen QJ; Shen WF
    J Zhejiang Univ Sci B; 2011 Aug; 12(8):652-9. PubMed ID: 21796806
    [TBL] [Abstract][Full Text] [Related]  

  • 6. AGEs-RAGE axis mediates myocardial fibrosis via activation of cardiac fibroblasts induced by autophagy in heart failure.
    Liang B; Zhou Z; Yang Z; Liu J; Zhang L; He J; Li H; Huang Y; Yang Q; Xian S; Wang L
    Exp Physiol; 2022 Aug; 107(8):879-891. PubMed ID: 35598104
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained Wnt/β-catenin signaling rescues high glucose induction of transforming growth factor-β1-mediated renal fibrosis.
    Ho C; Lee PH; Hsu YC; Wang FS; Huang YT; Lin CL
    Am J Med Sci; 2012 Nov; 344(5):374-82. PubMed ID: 22270399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huangkui capsule in combination with metformin ameliorates diabetic nephropathy via the Klotho/TGF-β1/p38MAPK signaling pathway.
    Gu LY; Yun-Sun ; Tang HT; Xu ZX
    J Ethnopharmacol; 2021 Dec; 281():113548. PubMed ID: 33152427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sympathoadrenergic suppression improves heart function by upregulating the ratio of sRAGE/RAGE in hypertension with metabolic syndrome.
    Selejan SR; Linz D; Tatu AM; Hohl M; Speer T; Ewen S; Mahfoud F; Kindermann I; Zamyatkin O; Kazakov A; Laufs U; Böhm M
    J Mol Cell Cardiol; 2018 Sep; 122():34-46. PubMed ID: 30096408
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between serum levels of soluble receptor for advanced glycation end products and circulating advanced glycation end products in type 2 diabetes.
    Tan KC; Shiu SW; Chow WS; Leng L; Bucala R; Betteridge DJ
    Diabetologia; 2006 Nov; 49(11):2756-62. PubMed ID: 16969649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of receptors of advanced glycation end products ameliorates diabetic osteogenesis of adipose-derived stem cells through DNA methylation and Wnt signalling pathway.
    Zhang M; Li Y; Rao P; Huang K; Luo D; Cai X; Xiao J
    Cell Prolif; 2018 Oct; 51(5):e12471. PubMed ID: 30014569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deletion of bone-marrow-derived receptor for AGEs (RAGE) improves renal function in an experimental mouse model of diabetes.
    Tesch G; Sourris KC; Summers SA; McCarthy D; Ward MS; Borg DJ; Gallo LA; Fotheringham AK; Pettit AR; Yap FY; Harcourt BE; Tan AL; Kausman JY; Nikolic-Paterson D; Kitching AR; Forbes JM
    Diabetologia; 2014 Sep; 57(9):1977-85. PubMed ID: 24957662
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Salidroside protects against diabetes mellitus-induced kidney injury and renal fibrosis by attenuating TGF-β1 and Wnt1/3a/β-catenin signalling.
    Shati AA; Alfaifi MY
    Clin Exp Pharmacol Physiol; 2020 Oct; 47(10):1692-1704. PubMed ID: 32472701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble Receptor for Advanced Glycation End-products regulates age-associated Cardiac Fibrosis.
    Scavello F; Zeni F; Milano G; Macrì F; Castiglione S; Zuccolo E; Scopece A; Pezone G; Tedesco CC; Nigro P; Degani G; Gambini E; Veglia F; Popolo L; Pompilio G; Colombo GI; Bianchi ME; Raucci A
    Int J Biol Sci; 2021; 17(10):2399-2416. PubMed ID: 34326683
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble receptors for advanced glycation end-products prevent unilateral ureteral obstruction-induced renal fibrosis.
    Kim CH; Kang HY; Kim G; Park J; Nam BY; Park JT; Han SH; Kang SW; Yoo TH
    Front Pharmacol; 2023; 14():1172269. PubMed ID: 37261287
    [No Abstract]   [Full Text] [Related]  

  • 16. Growth arrest specific 2-like protein 1 expression is upregulated in podocytes through advanced glycation end-products.
    Liebisch M; Bondeva T; Franke S; Hause S; Wolf G
    Nephrol Dial Transplant; 2017 Apr; 32(4):641-653. PubMed ID: 27638909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced expression of receptor for advanced glycation end-products is associated with low circulating soluble isoforms of the receptor in Type 2 diabetes.
    Tam XH; Shiu SW; Leng L; Bucala R; Betteridge DJ; Tan KC
    Clin Sci (Lond); 2011 Jan; 120(2):81-9. PubMed ID: 20726839
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study.
    Melin EO; Dereke J; Hillman M
    Lipids Health Dis; 2020 Oct; 19(1):223. PubMed ID: 33054750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of a disintegrin and metalloproteinase 10 in peripheral blood mononuclear cells in type 2 diabetes mellitus patients with the acute coronary syndrome: a pilot study.
    Ragavi R; Adole PS; Vinod KV; Pillai AA
    Endocrine; 2022 Sep; 77(3):461-468. PubMed ID: 35877008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum levels of advanced glycation end-products (AGEs) and the decoy soluble receptor for AGEs (sRAGE) can identify non-alcoholic fatty liver disease in age-, sex- and BMI-matched normo-glycemic adults.
    Palma-Duran SA; Kontogianni MD; Vlassopoulos A; Zhao S; Margariti A; Georgoulis M; Papatheodoridis G; Combet E
    Metabolism; 2018 Jun; 83():120-127. PubMed ID: 29409822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.